Alliance Pharma plc (LON:APH) is scheduled to release its earnings data before the market opens on Wednesday, September 13th.
Shares of Alliance Pharma plc (LON:APH) opened at 52.25 on Tuesday. The stock’s 50 day moving average is GBX 52.80 and its 200-day moving average is GBX 50.53. The firm’s market cap is GBX 246.99 million. Alliance Pharma plc has a 12-month low of GBX 41.33 and a 12-month high of GBX 57.50.
Several research analysts recently weighed in on the stock. FinnCap reissued a “buy” rating and set a GBX 58 ($0.75) price objective on shares of Alliance Pharma plc in a research note on Thursday, August 24th. Numis Securities Ltd reissued a “buy” rating and set a GBX 60 ($0.77) price objective on shares of Alliance Pharma plc in a research note on Tuesday, July 18th.
TRADEMARK VIOLATION NOTICE: “Alliance Pharma plc (APH) Set to Announce Earnings on Wednesday” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://sportsperspectives.com/2017/09/12/alliance-pharma-plc-aph-set-to-announce-earnings-on-wednesday.html.
Alliance Pharma plc Company Profile
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Ratings for Alliance Pharma plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma plc and related companies with MarketBeat.com's FREE daily email newsletter.